Thorough design and pre-trial quality assurance (QA) decrease dosimetric impact of delineation and dose planning variability in the STRICTLUNG and STARLUNG trials for stereotactic body radiotherapy (SBRT) of central and ultra-central lung tumours
L Hoffmann, G F Persson, L Nygård, T B Nielsen, S Borrisova, F Gaard-Petersen, M Josipovic, A A Khalil, R Kjeldsen, M M Knap, C Kristiansen, D S Møller, W Ottosson, H Sand, R Thing, M Pøhl, T Schytte, L Hoffmann, G F Persson, L Nygård, T B Nielsen, S Borrisova, F Gaard-Petersen, M Josipovic, A A Khalil, R Kjeldsen, M M Knap, C Kristiansen, D S Møller, W Ottosson, H Sand, R Thing, M Pøhl, T Schytte
Abstract
Introduction: SBRT of central lung tumours implies significant risk of toxicity. We are initiating two phase II trials prescribing 56 Gy/eight fractions to PTV, allowing for dose escalation of GTV. We prioritize organs at risk (OAR) constraints over target coverage, making the treatment plans very sensitive to OAR delineation variations. The aim of this study is to quantify the dosimetric impact of contouring variations and to provide a thorough description of pre-trial quality assurance to be used in upcoming trials to provide consistent clinical care.
Materials and methods: Delineation: Seven physicians delineated OAR in three rounds, with evaluations in-between. For each patient case, seven treatment plans, repeatedly using each of the OAR structure sets from the seven physicians, were made and compared to evaluate the dosimetric effect of delineation variability. Treatment planning: Treatment plans for seven cases were made at six departments in two rounds, with discussion in-between.
Results: OAR delineation variation between centres resulted in high variabilities in OAR dose for simulated plans and led to potential overdosage of the lobar bronchus (constraint: D0.03cc < 45 Gy), with maximum doses ranging between 58 Gy (first round), and 50 Gy (third round). For mediastinal tissue, the constraint (D0.03cc < 45 Gy) was violated for the majority of the delineations in all three rounds, with maximum doses of 84 Gy (first round), and 72 Gy (third round).For the treatment planning study, the range of the standard deviation for GTV mean dose was 12.8-18.5 Gy (first round) and 2.8-3.5 Gy (second round).
Conclusions: Even small variations in OAR delineation led to high OAR overdosage. The study demonstrates the importance of having extensive QA procedures in place before initiating clinical trials on dose escalation in SBRT.
Keywords: Central tumours; Lung tumours; Quality assurance; Stereotactic body radiotherapy.
Conflict of interest statement
Conflict of interest statement The authors have no conflicts of interests to report.
Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.
Source: PubMed
Nadchodzące badania kliniczne
-
Immuneering CorporationJeszcze nie rekrutacjaNiedrobnokomórkowy rak płuc z przerzutami | Lokalnie zaawansowany niedrobnokomórkowy rak płuca | Rak płuc (NSCLC) | NSCLC (zaawansowany niedrobnokomórkowy rak płuca) | Niepłaskonabłonkowy niedrobnokomórkowy rak płucStany Zjednoczone
-
Florida International UniversityNational Institute of Mental Health (NIMH); Oregon Health and Science UniversityJeszcze nie rekrutacjaAutyzmStany Zjednoczone
-
Envisioning Justice Solutions, IncRekrutacyjnyAgresja | Lęk | Problemy z gniewem | Depresja Zaburzenia lękowe | Zaburzenia związane z traumą i stresemStany Zjednoczone
-
Istituto Auxologico ItalianoRekrutacyjnyOtyłość i nadwaga | Obesity / OverweightWłochy
-
National Heart, Lung, and Blood Institute (NHLBI)Jeszcze nie rekrutacjaMakroglobulinemia WaldenstromaStany Zjednoczone
-
National Cancer Institute (NCI)Jeszcze nie rekrutacjaNiedrobnokomórkowego raka płuca | NSCLC | Rak płuc | Rak prostaty | mCRPC | Rak prostaty oporny na kastrację z przerzutami | Guzy nabłonka grasicy | TETs | Thymic Carcinomas | ThymomasStany Zjednoczone
-
National Institutes of Health Clinical Center (CC)Jeszcze nie rekrutacjaKrwiodawcy | AferezaStany Zjednoczone
-
National Institute of Dental and Craniofacial Research...Jeszcze nie rekrutacjaOtyłość | Obturacyjny bezdech senny (OSA) | Hipoplazja szczęki | Hipoplazja żuchwy | Pediatric Obstructive Sleep Apnea (OSA) | Adeno-Tonsillar Hypertrophy | Intraoral ApplianceStany Zjednoczone
-
National Institute of Mental Health (NIMH)RekrutacyjnyZdrowyStany Zjednoczone
-
National Heart, Lung, and Blood Institute (NHLBI)Jeszcze nie rekrutacjaKardiomiopatia przerostowa | Left Ventricular Outflow Obstruction | Systolic Anterior MotionStany Zjednoczone
-
National Institute of Neurological Disorders and...RekrutacyjnyDynamic Magnetic Resonance Imaging of Human Subarachnoid Space Using Intrathecal Gadolinium ContrastZdrowi WolontariuszeStany Zjednoczone
-
National Heart, Lung, and Blood Institute (NHLBI)Jeszcze nie rekrutacjaPrzewlekła białaczka limfocytowa | Mała białaczka limfocytowaStany Zjednoczone